High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial.

scientific article published on 12 April 2018

High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PONE.0195068
P932PMC publication ID5896909
P698PubMed publication ID29649309

P50authorJuan PasquauQ56863306
Samantha Elizabeth de JesusQ59702693
Alberto Romero PalaciosQ81565702
P2093author name stringArkaitz Imaz
José Hernández-Quero
María Carmen Fariñas
Fernando Lozano
Koldo Aguirrebengoa
Pilar Vázquez
Juan Flores
María José Galindo
Isabel Sanjoaquín
Jorge Vergas
Carmen Hidalgo-Tenorio
Ignacio de Los Santos
María Luisa Montes
María José Ríos-Villegas
Francisco Orihuela
Coral García-Vallecillos
Isabel García-Mercé
QoLKAMON STUDY GROUP
P2860cites workSimplification of antiretroviral therapy: a good choice for our patients and the sustainability of our health care system.Q45974592
Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis.Q46059384
Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression.Q46460347
Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scaleQ46572937
The level of persistent HIV viremia does not increase after successful simplification of maintenance therapy to lopinavir/ritonavir aloneQ58000879
Análisis farmacoeconómico de una estrategia de mantenimiento con lopinavir/ritonavir como monoterapia en pacientes con infección por el VIHQ58000881
Lopinavir/ritonavir monotherapy as a simplification strategy in routine clinical practiceQ80446898
[Validation of a questionnaire to estimate satisfaction with antiretroviral treatment: CESTA questionnaire]Q81567538
Pilot, randomized study assessing safety, tolerability and efficacy of simplified LPV/r maintenance therapy in HIV patients on the 1 PI-based regimenQ28741214
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.Q34289633
Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literatureQ34535751
Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South AfricaQ34734833
CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentQ35193958
Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trialQ36613143
Boosted protease inhibitor monotherapy in HIV-infected adults: outputs from a pan-European expert panel meetingQ36722728
Lopinavir/ritonavir in the treatment of HIV-1 infection: a review.Q37052827
Molecular basis of human immunodeficiency virus drug resistance: an update.Q37555266
Boosted protease inhibitor monotherapy. What have we learnt after seven years of research?Q37788957
Protease inhibitor monotherapy.Q37819920
Iatrogenic mitochondriopathies: a recent lesson from nucleoside/nucleotide reverse transcriptase inhibitors.Q37991644
Protease inhibitor monotherapy as maintenance regimen in patients with HIV infectionQ38046883
Responsiveness of the MOS-HIV and EQ-5D in HIV-infected adults receiving antiretroviral therapiesQ38089967
Central nervous system HIV infection in "less-drug regimen" antiretroviral therapy simplification strategiesQ38203208
Lopinavir/ritonavir monotherapy versus current treatment continuation for maintenance therapy of HIV-1 infection: the KALESOLO trialQ38499842
Assessment of second-line antiretroviral regimens for HIV therapy in AfricaQ38861912
A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy.Q40082978
Effect of lopinavir/ritonavir monotherapy on quality of life and self-reported symptoms among antiretroviral-naive patients: results of the MONARK trial.Q42663879
Protease inhibitor resistance analysis in the MONARK trial comparing first-line lopinavir-ritonavir monotherapy to lopinavir-ritonavir plus zidovudine and lamivudine triple therapyQ43102710
Impact of 48 week lopinavir/ritonavir monotherapy on blood cell-associated HIV-1-DNA in the MONARK trialQ43124622
Monotherapy with Lopinavir/Ritonavir as maintenance after HIV-1 viral suppression: results of a 96-week randomized, controlled, open-label, pilot trial (KalMo study).Q43172783
Changes in quality of life among persons with HIV infectionQ43409011
Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA StudyQ43901817
Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.Q44043469
Budget impact analysis of switching to darunavir/ritonavir monotherapy for HIV-infected people in SpainQ44583194
Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudineQ44710862
[Lopinavir/ritonavir monotherapy as a simplification strategy in antiretroviral therapy in clinical practice].Q45942565
[Lopinavir/ritonavir monotherapy. Possible indications].Q45942567
[Lopinavir/ritonavir monotherapy as a simplification strategy in the treatment of HIV-1 infection].Q45942570
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectlopinavirQ422585
ritonavirQ422618
lopinavir/ritonavirQ3836750
P304page(s)e0195068
P577publication date2018-04-12
P1433published inPLOS OneQ564954
P1476titleHigh quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial
P478volume13

Reverse relations

cites work (P2860)
Q58122670Comparison of Zidovudine and Tenofovir Based Regimens With Regard to Health-Related Quality of Life and Prevalence of Symptoms in HIV Patients in a Kenyan Referral Hospital
Q95641549Efficacy and safety of lopinavir/ritonavir or arbidol in adult patients with mild/moderate COVID-19: an exploratory randomized controlled trial
Q90675802HPV-associated anal lesions in HIV+ patients: long-term results regarding quality of life

Search more.